Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2007 Oct 17.

Published in final edited form as: Circulation. 2007 Apr 2;115(15):1982–1990. doi: 10.1161/CIRCULATIONAHA.106.659763

Table 1. Subject characteristics.

	CON (n=617)	HTN (n=719)	HfnlEF (n=244)
Age (range), years	57 (45–96)	66 (46–91)^*	76 (22–99) ^*^†
Males, %	45	44	45
Height, cm	169±10	167±10^*	165±13^*
Weight, kg	73±13	84±19^*	86±25^*
Body surface area, m²	1.85±0.21	1.96±0.26^*	1.97±0.31^*
Body mass index, kg/m²	25.4±2.7	29.8±5.9^*	32.2±20.7^*^†
Hypertension, %	0	100^*	96^*
Coronary artery disease, %	0	16^*	53^*^†
Diabetes mellitus, %	0	11^*	37^*^†
Glomerular filtration rate, ml/min/1.73m²	74.4±14.1	74.7±37.0	64.3±28.1^*^†
BNP (Shionogi), pg/ml	20.0±40.3	30.5±45.2^*	260.7±330.2^*^†
Log BNP (Shionogi, pg/ml)	1.06±0.41	1.23±0.46^*	2.15±0.55^*^†
Ejection fraction, %	63±5	65±6	62±6^*^†
Heart rate, bpm	65±10	67±12	71±15^*^†
Systolic blood pressure, mmHg	118±12	143±21^*	132±23^*^†
Diastolic blood pressure, mmHg	70±8	76±11^*	67±14^†
Pulse pressure, mmHg	48±11	67±18^*	65±20^*

Data are mean ± SD unless otherwise stated. Unadjusted analysis.

^*

p<0.05 vs CON;

^†

p<0.05 vs HTN

BSA, body surface area; BNP, B-type natriuretic peptide

HHS Vulnerability Disclosure